Skip to Main Content

Author Details

Marcel Kool
Hopp Children's Cancer Center (KiTZ)
1990
329
90
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36356895Rare embryonal and sarcomatous central nervous system tumours: State-of-the art and future directions.Eur J Med Genet2023
36356895Rare embryonal and sarcomatous central nervous system tumours: State-of-the art and future directions.Eur J Med Genet2023
37679810Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours.Genome Med2023
37835571The Site of Origin of Medulloblastoma: Surgical Observations Correlated to Molecular Groups.Cancers (Basel)2023
37883081Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial.JAMA Oncol2023
37093271Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypes.Acta Neuropathol2023
36715306Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroups.Neuro Oncol2023
37277823Group-specific cellular metabolism in Medulloblastoma.J Transl Med2023
370855393D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.Nat Commun2023
37020198The potential of PARP as a therapeutic target across pediatric solid malignancies.BMC Cancer2023
37020038Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities.Oncogene2023
36765089Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability.Nat Commun2023
36702933Comprehensive analysis of mutational signatures reveals distinct patterns and molecular processes across 27 pediatric cancers.Nat Cancer2023
36635768Comparison of transcriptome profiles between medulloblastoma primary and recurrent tumors uncovers novel variance effects in relapses.Acta Neuropathol Commun2023
37450044Recurrent atypical teratoid/rhabdoid tumors (AT/RT) reveal discrete features of progression on histology, epigenetics, copy number profiling, and transcriptomics.Acta Neuropathol2023
37441939Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.Eur J Cancer2023
37379234Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.Neuro Oncol2023
37183219Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells.J Neurooncol2023
36459208Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts.Acta Neuropathol2023
37501103Mitochondrial DNA mutations in Medulloblastoma.Acta Neuropathol Commun2023
36782314CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult population.Acta Neuropathol Commun2023
37835571The Site of Origin of Medulloblastoma: Surgical Observations Correlated to Molecular Groups.Cancers (Basel)2023
37883081Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial.JAMA Oncol2023
37501103Mitochondrial DNA mutations in Medulloblastoma.Acta Neuropathol Commun2023
37679810Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours.Genome Med2023
370855393D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.Nat Commun2023
37020198The potential of PARP as a therapeutic target across pediatric solid malignancies.BMC Cancer2023
37020038Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities.Oncogene2023
37450044Recurrent atypical teratoid/rhabdoid tumors (AT/RT) reveal discrete features of progression on histology, epigenetics, copy number profiling, and transcriptomics.Acta Neuropathol2023
37183219Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells.J Neurooncol2023
37379234Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.Neuro Oncol2023
37277823Group-specific cellular metabolism in Medulloblastoma.J Transl Med2023
37441939Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.Eur J Cancer2023
37093271Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypes.Acta Neuropathol2023
36782314CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult population.Acta Neuropathol Commun2023
36715306Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroups.Neuro Oncol2023
36765089Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability.Nat Commun2023
36635768Comparison of transcriptome profiles between medulloblastoma primary and recurrent tumors uncovers novel variance effects in relapses.Acta Neuropathol Commun2023
36459208Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts.Acta Neuropathol2023
36702933Comprehensive analysis of mutational signatures reveals distinct patterns and molecular processes across 27 pediatric cancers.Nat Cancer2023
33283872Corrigendum to: Molecular subgrouping of atypical teratoid/rhabdoid tumors-a reinvestigation and current consensus.Neuro Oncol2022
36182817Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program 'iTHER'.Eur J Cancer2022
36180532Multispectral confocal 3D imaging of intact healthy and tumor tissue using mLSR-3D.Nat Protoc2022
35771282Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expression.Acta Neuropathol2022
35446794SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors With Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation of Li-Fraumeni Syndrome.Am J Surg Pathol2022
36291912Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a "MEMMAT-like" Metronomic Antiangiogenic Approach.Cancers (Basel)2022
35831316The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors.Nat Commun2022
35501487ATRT-SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significance.Acta Neuropathol2022
36137662Imaging Characteristics of CNS Neuroblastoma-<i>FOXR2</i>: A Retrospective and Multi-Institutional Description of 25 Cases.AJNR Am J Neuroradiol2022
36127323Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumors.Cell Death Dis2022
  • 1 - 50 of 658

Recommended Authors

College of Medicine, The Ohio State University
Career Start Year 2017
Number of shared co-authors 7
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2014
Number of shared co-authors 29
National Cancer Institute
Career Start Year 2013
Number of shared co-authors 30
Graduate School of Medicine, Kyoto University
Career Start Year 2012
Number of shared co-authors 91
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2012
Number of shared co-authors 27
University of California san francisco
Career Start Year 2010
Number of shared co-authors 32
National Cancer Institute
Career Start Year 2009
Number of shared co-authors 29
Maharaja Agrasen Medical College
Career Start Year 2009
Number of shared co-authors 30
University of Manitoba
Career Start Year 2007
Number of shared co-authors 66
Oregon Health & Science University
Career Start Year 2007
Number of shared co-authors 38
University of Colorado Anschutz Medical Campus
Career Start Year 2004
Number of shared co-authors 5
Seve Ballesteros Foundation Brain Tumor group
Career Start Year 2002
Number of shared co-authors 15
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 2002
Number of shared co-authors 25
Center for Cancer Research, National Cancer Institute
Career Start Year 2001
Number of shared co-authors 25
University of Manitoba
Career Start Year 2001
Number of shared co-authors 66
Institut Curie
Career Start Year 2000
Number of shared co-authors 23
St. Jude Children's Research Hospital
Career Start Year 1999
Number of shared co-authors 39
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 5
Center for Biomedical Informatics and Information Technology
Career Start Year 1996
Number of shared co-authors 7
NYU Grossman School of Medicine
Career Start Year 1995
Number of shared co-authors 35
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1994
Number of shared co-authors 44
Center for Cancer Research, National Cancer Institute
Career Start Year 1993
Number of shared co-authors 51
University of California san francisco
Career Start Year 1991
Number of shared co-authors 53
Broad Institute of Harvard and MIT
Career Start Year 1990
Number of shared co-authors 14
University of California San Francisco
Career Start Year 1989
Number of shared co-authors 29
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Career Start Year 1989
Number of shared co-authors 48
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 1989
Number of shared co-authors 22
Children's Hospital of Los Angeles
Career Start Year 1988
Number of shared co-authors 19
Children's Hospital of Philadelphia
Career Start Year 1985
Number of shared co-authors 83
Children's Cancer Therapy Development Institute
Career Start Year 1980
Number of shared co-authors 15

Collaborators

Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 198
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 133
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 110
The Hospital for Sick Children
Co-authored papers 72
St Jude Children's Research Hospital
Co-authored papers 68
Co-authored papers 67
German Cancer Research Center (DKFZ)
Co-authored papers 61
University Medical Center Hamburg-Eppendorf
Co-authored papers 47
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 47
N.N. Burdenko Neurosurgical Institute
Co-authored papers 46
University Medical Center Hamburg-Eppendorf
Co-authored papers 45
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 44
Co-authored papers 42
Co-authored papers 40
Co-authored papers 40
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 39
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 38
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers 38
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 38
Hospital for Sick Children
Co-authored papers 36
Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University
Co-authored papers 36
Charite University Medicine Berlin
Co-authored papers 33
Co-authored papers 31
Co-authored papers 31
Amsterdam University Medical Centers location AMC
Co-authored papers 30
Co-authored papers 29
St. Jude Children's Research Hospital
Co-authored papers 28
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 26
Co-authored papers 25
University of California San Diego
Co-authored papers 25